U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI) Workshop on Celiac Disease - 07/22/2021 - 07/22/2021
  1. News & Events for Human Drugs

Workshop | Virtual

Event Title
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI) Workshop on Celiac Disease
July 22, 2021

Date:
July 22, 2021

 

Workshop Summary

The goal of the GREAT VI workshop is to discuss the overall approach to drug development in celiac disease that includes an assessment of both clinical symptoms and histology. The workshop will focus the discussion on the histologic endpoints to assess treatment benefit in patients with celiac disease; regulatory framework for pediatric drug development in celiac disease; and the role of gluten challenge in clinical trials to provide a forum for open discussion between stakeholders to facilitate drug development.

About the Workshop

FDA is announcing a public workshop for celiac disease. Discussions will focus on the approach to drug development in celiac disease and include the following topic areas:

  • The histologic endpoints to assess treatment benefit in patients with celiac disease
  • Regulatory framework for pediatric drug development in celiac disease
  • The role of gluten challenge in clinical trials

Event Registration

To participate in the virtual workshop, please register by July 22, 2021 at https://www.eventbrite.com/e/145322155479

Meeting Materials

Agenda (Final) (PDF - 73KB)

A full agenda will be available one week before the workshop.

​Topic: Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (Great VI): Workshop on Celiac Disease

Date: Jul 22, 2021 08:25 AM Eastern Time (US and Canada)

Meeting Recording:

Access Passcode: E1&n=Y8z

Disclaimer: Please note that the closed-captions for this meeting were auto-generated and may include errors. Please view the full transcript report if you experience closed-caption discrepancies. 

Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI):
Workshop on Celiac Disease (PDF - 5.12MB)

Contact

For any addition questions or concerns please contact DG Workshops at DGWorkshops@fda.hhs.gov.

 

 

 
Back to Top